Trial Profile
A phase IIb/IIIa patient crossover study of RPI 78M for the treatment of adrenomyeloneuropathy
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs RPI 78M (Primary)
- Indications Adrenomyeloneuropathy
- Focus Therapeutic Use
- 20 Jul 2015 New trial record